Early Detection Research Network

Ovary

In laboratory testing, APOA1, in a panel (including transthyretin, transferrin, and CA125) has been shown to be a highly sensitive (96%) predictor of early stage ovarian cancer and endometrial cancer.
http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/223/254
Curated
Three
Of the 28 ovarian cancer biomarkers tested in prediagnostic specimens, from the PLCO, CA125 remains the single best biomarker for ovarian cancer and has its strongest signal within six months of diagnosis. APOA1 alone was not a strong predictor.
22e8d394562348d4a780822980f5add9
no
no
Contents

There are currently no items in this folder.